Among 104 patients with adenoma, 91 showed positive CYP11B2 immunostaining in their tumors; whereas 11 patients showing multiple CYP11B2-positive immunostaining tumors were considered as multiple APAs (Figure 1). This evidence concerns the gene CYP11B2 and adenoma.